Neogen Corp. (NASDAQ:NEOG) shares reached a new 52-week high on Friday . The stock traded as high as $60.60 and last traded at $60.25, with a volume of 45,225 shares traded. The stock had previously closed at $59.52.

Several research analysts have recently weighed in on NEOG shares. Craig Hallum raised shares of Neogen Corp. from a “hold” rating to a “buy” rating in a report on Tuesday, August 9th. Zacks Investment Research raised shares of Neogen Corp. from a “sell” rating to a “hold” rating in a report on Friday, June 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. Neogen Corp. currently has a consensus rating of “Hold” and an average target price of $57.25.

The company’s 50-day moving average price is $56.73 and its 200-day moving average price is $52.05. The stock has a market cap of $2.29 billion and a price-to-earnings ratio of 62.79.

Neogen Corp. (NASDAQ:NEOG) last issued its quarterly earnings results on Tuesday, July 19th. The company reported $0.26 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.26. The business had revenue of $90.10 million for the quarter, compared to analysts’ expectations of $86.27 million. Equities analysts forecast that Neogen Corp. will post $1.13 EPS for the current year.

In other news, Director Jack C. Parnell sold 5,000 shares of Neogen Corp. stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $56.87, for a total transaction of $284,350.00. Following the transaction, the director now owns 13,555 shares in the company, valued at approximately $770,872.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Edward Bradley sold 20,196 shares of Neogen Corp. stock in a transaction on Monday, August 1st. The stock was sold at an average price of $55.60, for a total transaction of $1,122,897.60. Following the transaction, the vice president now owns 126,730 shares in the company, valued at approximately $7,046,188. The disclosure for this sale can be found here.

Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.